Pharmacists in Beaver Dam, Wisconsin


29 Pharmacists found in Beaver Dam
female pharmacist

Mae Barredo


Pharmacist
120 Frances Ln, Beaver Dam, WI 53916
920-885-5808    

female pharmacist

Ms. Mary Fanshaw, PHARMD


Pharmacist
607 Park Ave, Beaver Dam, WI 53916
920-356-0148    

male pharmacist

Dr. Michael Dull Ii, PHARMD


Pharmacist
822 Park Ave, Beaver Dam, WI 53916
920-887-7511    



male pharmacist

Mike Leahan, RPH


Pharmacist
822 Park Ave, Beaver Dam, WI 53916
920-887-7511     920-887-0725

female pharmacist

Pamela Webb


Pharmacist
607 Park Ave, Beaver Dam, WI 53916
920-356-0148     920-356-0401

female pharmacist

Raquel Rodriguez-guzman, PHARMD


Pharmacist
205 La Crosse Street, Beaver Dam, WI 53916
920-219-9212    

female pharmacist

Ronay Bjerke


Pharmacist
705 S University Ave, Suite 180, Beaver Dam, WI 53916
920-356-0040    

male pharmacist

Scott Michael Farrell, DPHARM


Pharmacist
607 Park Ave, Beaver Dam, WI 53916
920-356-0148     920-356-0401

male pharmacist

Sean K Wiemann, PHARM D.


Pharmacist
607 Park Ave, Beaver Dam, WI 53916
920-356-0148    

female pharmacist

Sherry Bisbee


Pharmacist
705 S University Ave, Beaver Dam, WI 53916
920-356-0040    

female pharmacist

Susan Lorraine Sutter, R.PH.


Pharmacist
705 S University Ave, Suite 180, Beaver Dam, WI 53916
920-356-0040     920-356-0056

female pharmacist

Taylor Christian Lang, PHARMD


Pharmacist
120 Frances Ln, Beaver Dam, WI 53916
920-885-5808    

male pharmacist

William Perego


Pharmacist
120 Frances Ln, Beaver Dam, WI 53916
920-885-5808    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.